News
-
S4 codeine supply slump
Friday | Apr 26 2019LAST year's up-scheduling of codeine medications to prescription-only (Schedule 4) has resulted in a significant decrease in the amount of codeine supplied to Australian patients, according to new figures released by the Therapeutic Goods Administration (TGA).
-
Adele sticks it to Senator
Friday | Apr 26 2019NSW Pharmacy Guild Branch Committee member and pharmacy owner, Adele Tahan, administered a flu vaccination to NSW Senator Kristina Keneally yesterday.
-
Duckett plots PBS savings
Friday | Apr 26 2019PHARMACY ownership rules need to be reformed to cut red tape and reduce Pharmaceutical Benefits Scheme (PBS) costs, Grattan Institute Health Program Director, Stephen Duckett, believes.
-
VPA lifts pharmacy licence fees
Friday | Apr 26 2019VICTORIAN pharmacy owners face a 12% increase in licence, registration and application fees from 01 May, following an announcement by the Victorian Pharmacy Authority (VPA).
-
Welsh pharmacy scripts test
Friday | Apr 26 2019COMMUNITY pharmacists in Wales are conducting trials to determine whether a "test and treat" scheme at community pharmacies may alleviate stress on general practitioners and increase appropriate antibiotic prescriptions.
-
FIP workforce push
Friday | Apr 26 2019THE International Pharmaceutical Federation (FIP) has launched a new program designed to advance pharmaceutical workforces across the globe.
-
FDA affirms MMR safe
Friday | Apr 26 2019THE US Food and Drug Administration (FDA) has issued a formal statement expressing its continued confidence in the safety and effectiveness of the measles, mumps and rubella (MMR) vaccine.
-
More nicotine to quit
Friday | Apr 26 2019USING higher doses in nicotine replacement therapy (NRT) when attempting to quit smoking is more effective than lower doses, according to new UK research.
-
Fight flu with phytos
Friday | Apr 26 2019UNIVERSITY of Sydney researchers have published new studies explaining how a popular ancient remedy, the elderberry fruit, can help the fight against influenza.
-
EMA Lynparza alert
Friday | Apr 26 2019THE European Medicines Agency (EMA) has issued a risk alert around cancer medicine Lynparza (olaparib) which is marketed in Australia by AstraZeneca.
